This application requests renewal of a grant to provide advanced, state-of-the-art training in two active and closely related fields, angiogenesis and inflammation. Training of new scientists and physician-scientists in these areas is vital to the continued discovery of basic mechanisms that regulate these processes, which are central to many human diseases. Despite a growing need, few opportunities provide broad, in depth, interdisciplinary training for individuals to investigate the complex and interrelated processes that regulate normal and pathological angiogenesis and inflammatory responses. The training is based in the Department of Pathology at the Beth Israel Deaconess Medical Center (BIDMC) and focuses on both basic and translational research. The training program for each participant includes four components, (a) research training in one or more faculty member's laboratory, (b) participation in seminar series as speakers and attendees, (c) participation in a program on the responsible conduct of research (RCR), and (d) participation in relevant graduate courses offered by Harvard Medical School and Harvard University. The members of the training faculty have been selected on the basis of their commitment to mentoring and collaborative research. They will mentor the trainees in the insightful design of experiments with appropriate controls, grant writing, career development, and the RCR. Many of the faculty members have shared projects and trainees are encouraged to participate in these collaborative projects, which offer an opportunity to learn new methodologies. The program faculty members have extensive experience in biochemistry, cell biology, molecular biology, pathology and animal models of disease. The trainees will gain experience with new technologies in the fields of genomics, proteomics and molecular diagnostics, stem cell biology, computational modeling and bioinformatics. As part of the Harvard Medical School and the Longwood Medical Area, the BIDMC is ideally positioned to provide trainees with experience in state-of-the-art technologies and opportunities to interact with outstanding scientists. We propose to train six postdoctoral fellows each year, selected from applicants with Ph.D., M.D., or M.D./Ph.D. degrees. The BIDMC and Harvard Medical School have a strong commitment to the recruitment, retention, and encouragement of under-represented minorities, the disabled and individuals from disadvantaged backgrounds.
Angiogenesis and inflammation are central processes in many physiological and pathological conditions, including cancer. This application requests renewal of a grant to provide advanced, state-of-the-art training in two active and closely related fields, angiogenesis and inflammation. Despite a growing need, few opportunities provide broad, in depth, interdisciplinary training for individuals to investigate the complex and interrelated processes that regulate angiogenesis and inflammatory responses.
|Zhang, Jinfang; Xu, Kai; Liu, Pengda et al. (2016) Inhibition of Rb Phosphorylation Leads to mTORC2-Mediated Activation of Akt. Mol Cell 62:929-42|
|Zurlo, Giada; Guo, Jianping; Takada, Mamoru et al. (2016) New Insights into Protein Hydroxylation and Its Important Role in Human Diseases. Biochim Biophys Acta 1866:208-220|
|Thornley, Thomas B; Agarwal, Krishna A; Kyriazis, Periklis et al. (2016) Contrasting Roles of Islet Resident Immunoregulatory Macrophages and Dendritic Cells in Experimental Autoimmune Type 1 Diabetes. PLoS One 11:e0150792|
|DuBrock, Hilary M; Kradin, Richard L; Rodriguez-Lopez, Josanna M et al. (2015) Pulmonary capillary hemangiomatosis: the role of invasive cardiopulmonary exercise testing. Pulm Circ 5:580-6|
|Sims, Jennifer N; Lawler, Jack (2015) Thrombospondin-1-Based Antiangiogenic Therapy. J Ocul Pharmacol Ther 31:366-70|
|DuBrock, Hilary M; Channick, Richard N; Krowka, Michael J (2015) What's new in the treatment of portopulmonary hypertension? Expert Rev Gastroenterol Hepatol 9:983-92|
|Wang, Zhiwei; Dai, Xiangpeng; Zhong, Jiateng et al. (2015) SCF(Î²-TRCP) promotes cell growth by targeting PR-Set7/Set8 for degradation. Nat Commun 6:10185|
|Duquette, Mark; Sadow, Peter M; Husain, Amjad et al. (2015) Metastasis-associated MCL1 and P16 copy number alterations dictate resistance to vemurafenib in a BRAFV600E patient-derived papillary thyroid carcinoma preclinical model. Oncotarget 6:42445-67|
|Moraes-Vieira, Pedro M M; Larocca, Rafael A; Bassi, Enio J et al. (2014) Leptin deficiency impairs maturation of dendritic cells and enhances induction of regulatory T and Th17 cells. Eur J Immunol 44:794-806|
|Sadow, Peter M; Priolo, Carmen; Nanni, Simona et al. (2014) Role of BRAFV600E in the first preclinical model of multifocal infiltrating myopericytoma development and microenvironment. J Natl Cancer Inst 106:|
Showing the most recent 10 out of 39 publications